N-myc downstream-regulated gene 1/Cap43 may function as tumor suppressor in endometrial cancer

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 10, 2012, Pages 1703-1715

  Lv, Xiu Hong ^a   Chen, Jia Wei ^a   Zhao, Gang ^b   Feng, Zhen Zhong ^c   Yang, Dao Hua ^a   Sun, Wei Wei ^a   Fan, Jin Shuang ^d   Zhu, Guang Hui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c BENGBU MEDICAL COLLEGE   (China)

^d Si Jing Hospital   (China)

Author keywords

CDNA microarray analysis; Endometrial cancer; Invasion; NDRG1; Proliferation; ShRNA

Indexed keywords

ACTIN; SHORT HAIRPIN RNA;

ACPP GENE; ACTIN GENE; ADM2 GENE; AMY2B GENE; ARHGAP19 GENE; ARTICLE; C20ORF74 GENE; CACNA1H GENE; CANCER CELL; CANCER INHIBITION; CARCINOGENESIS; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CNN1 GENE; COLONY FORMATION; CONTROLLED STUDY; DLX3 GENE; DNA VECTOR; ENDOMETRIUM CANCER; FAM20C GENE; FLJ32784 GENE; FST GENE; GENE; GENE CONTROL; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; HIST1H2BG GENE; HUMAN; HUMAN CELL; IGF1 GENE; IL9 GENE; IN VITRO STUDY; LALBA GENE; LIPE GENE; MICROARRAY ANALYSIS; NALP1 GENE; NDRG1 GENE; PRIORITY JOURNAL; PTPRZ1 GENE; SGPP2 GENE; SLC29A4 GENE; SPARC GENE; TMPRSS4 GENE; TUMOR SUPPRESSOR GENE;

CELL CYCLE PROTEINS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASM INVASIVENESS; PROSPECTIVE STUDIES;

EID: 84866740950     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1249-4     Document Type: Article

References (38)

1. Angst E, Dawson DW, Stroka D, Gloor B, Park J, Candinas D, Reber HA, Hines OJ, Eibl G (2011) N-myc downstream regulated gene-1 expression correlates with reduced pancreatic cancer growth and increased apoptosis in vitro and in vivo. Surgery 149(5):614-624. doi:10.1016/j.surg.2010.11.002
2. Bandyopadhyay S, Pai SK, Gross SC, Hirota S, Hosobe S, Miura K, Saito K, Commes T, Hayashi S, Watabe M, Watabe K (2003) The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res 63(8):1731-1736
3. Bandyopadhyay S, Pai SK, Hirota S, Hosobe S, Takano Y, Saito K, Piquemal D, Commes T, Watabe M, Gross SC, Wang Y, Ran S, Watabe K (2004a) Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene 23(33):5675-5681. doi:10.1038/sj.onc.1207734
4. Bandyopadhyay S, Pai SK, Hirota S, Hosobe S, Tsukada T, Miura K, Takano Y, Saito K, Commes T, Piquemal D, Watabe M, Gross S, Wang Y, Huggenvik J, Watabe K (2004b) PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer. Cancer Res 64(21):7655-7660. doi:10.1158/0008-5472. can-04-1623
5. Bandyopadhyay S, Wang Y, Zhan R, Pai SK, Watabe M, Iiizumi M, Furuta E, Mohinta S, Liu W, Hirota S, Hosobe S, Tsukada T, Miura K, Takano Y, Saito K, Commes T, Piquemal D, Hai T, Watabe K (2006) The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer. Cancer Res 66(24):11983-11990. doi: 10.1158/0008-5472.can-06- 0943
6. Cangul H (2004) Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers. BMC Genet 5:27. doi:10.1186/1471-2156-5-27
7. Chen J, Li S, Yang Z, Lu G, Hu H (2008) Correlation between NDRG1 and PTEN expression in endometrial carcinoma. Cancer Sci 99(4):706-710. doi:10.1111/j.1349-7006.2008.00749.x
8. Chen S, Han Y-H, Zheng Y, Zhao M, Yan H, Zhao Q, Chen G-Q, Li D (2009) NDRG1 contributes to retinoic acid-induced differentiation of leukemic cells. Leuk Res 33(8):1108-1113. doi:10.1016/j.leukres.2008.10.016
9. Cheng J, Xie HY, Xu X, Wu J, Wei XY, Su R, Zhang W, Lv Z, Zheng SS, Zhou L (2011) NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma. Cancer Lett 310(1):35-45. doi:10.1016/j.canlet. 2011.06.001
10. Chuang TD, Chen SJ, Lin FF, Veeramani S, Kumar S, Batra SK, Tu Y, Lin MF (2010) Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth. J Biol Chem 285(31):23598-23606. doi:10.1074/jbc.M109.098301
11. Duong LM, Wilson RJ, Ajani UA, Singh SD, Eheman CR (2011) Trends in endometrial cancer incidence rates in the United States, 1999-2006. J Womens Health (Larchmt) 20(8):1157-1163. doi:10.1089/jwh.2010.2529
12. Evans T, Sany O, Pearmain P, Ganesan R, Blann A (2006) Sundar S (2011) Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to. Br J Cancer 104(9):1505-1510. doi:10.1038/bjc. 2011.68
13. Fotovati A, Fujii T, Yamaguchi M, Kage M, Shirouzu K, Oie S, Basaki Y, Ono M, Yamana H, Kuwano M (2006) 17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells. Clin Cancer Res 12(10):3010-3018. doi:10.1158/1078-0432.ccr-05-1962
14. Gao X, Wei S, Lai K, Sheng J, Su J, Zhu J, Dong H, Hu H, Xu Z (2010) Nucleolar follistatin promotes cancer cell survival under glucose-deprived conditions through inhibiting cellular rRNA synthesis. J Biol Chem 285(47):36857-36864. doi:10.1074/jbc. M110.144477
15. Holysz M, Derebecka-Holysz N, Trzeciak WH (2011) Transcription of LIPE gene encoding hormone-sensitive lipase/cholesteryl esterase is regulated by SF-1 in human adrenocortical cells: involvement of protein kinase A signal transduction pathway. J Mol Endocrinol 46(1):29-36. doi:10.1677/jme-10-0035
16. Hosoi F, Izumi H, Kawahara A, Murakami Y, Kinoshita H, Kage M, Nishio K, Kohno K, Kuwano M, Ono M (2009) N-myc Downstream Regulated Gene 1/Cap43 Suppresses Tumor Growth and Angiogenesis of Pancreatic Cancer through Attenuation of Inhibitor of kappa B Kinase beta Expression. Cancer Res 69(12):4983-4991. doi:10.1158/0008-5472.can-08-4882
17. Jung H, Lee KP, Park SJ, Park JH, Jang YS, Choi SY, Jung JG, Jo K, Park DY, Yoon JH, Lim DS, Hong GR, Choi C, Park YK, Lee JW, Hong HJ, Kim S, Park YW (2008) TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition. Oncogene 27(18):2635-2647. doi:10.1038/sj.onc.1210914
18. Kalaydjieva L, Gresham D, Gooding R, Heather L, Baas F, de Jonge R, Blechschmidt K, Angelicheva D, Chandler D, Worsley P, Rosenthal A, King RHM, Thomas PK (2000) N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. Am J Hum Genet 67(1):47-58. doi: 10.1086/302978
19. Kaneko M, Takeoka M, Oguchi M, Koganehira Y, Murata H, Ehara T, Tozuka M, Saida T, Taniguchi SI (2002) Calponin h1 suppresses tumor growth of Src-induced transformed 3Y1 cells in association with a decrease in angiogenesis. Cancer Sci 93(8):935-943. doi:10.1111/j.1349-7006.2002.tb01340.x
20. Kim K, Zang R, Choi SC, Ryu SY, Kim JW (2009) Current status of gynecological cancer in China. J Gynecol Oncol 20(2):72-76. doi:10.3802/jgo. 2009.20.2.72
21. Kovacevic Z, Richardson DR (2006) The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer. Carcinogenesis 27(12):2355-2366. doi:10.1093/carcin/bgl146
22. Kovacevic Z, Sivagurunathan S, Mangs H, Chikhani S, Zhang D, Richardson DR (2011) The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via p53-independent mechanisms. Carcinogenesis 32(5):732-740. doi:10.1093/carcin/bgr046
23. Li W, Zhang SL, Wang N, Zhang BB, Li M (2011) Blockade of T-type Ca(2+) channels inhibits human ovarian cancer cell proliferation. Cancer Invest 29(5):339-346. doi:10.3109/07357907.2011.568565
24. Liu W, Iiizumi-Gairani M, Okuda H, Kobayashi A, Watabe M, Pai SK, Pandey PR, Xing F, Fukuda K, Modur V, Hirota S, Suzuki K, Chiba T, Endo M, Sugai T, Watabe K (2011) KAI1 geneisengaged in NDRG1 gene-mediated metastasis suppression through the ATF3-NFkappaB complex in human prostate cancer. JBiol Chem 286(21):18949-18959. doi:10.1074/jbc.M111.232637
25. Maruyama Y, Ono M, Kawahara A, Yokoyama T, Basaki Y, Kage M, Aoyagi S, Kinoshita H, Kuwano M (2006) Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Cancer Res 66(12):6233-6242. doi:10.1158/0008-5472.CAN-06-0183
26. Mechtcheriakova D, Wlachos A, Sobanov J, Kopp T, Reuschel R, Bornancin F, Cai R, Zemann B, Urtz N, Stingl G, Zlabinger G, Woisetschlager M, Baumruker T, Billich A (2007) Sphingosine 1-phosphate phosphatase 2 is induced during inflammatory responses. Cell Signal 19(4):748-760. doi:10.1016/j.cellsig. 2006.09.004
27. Nagai MA, Gerhard R, Fregnani JH, Nonogaki S, Rierger RB, Netto MM, Soares FA (2011) Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients. Breast Cancer Res Treat 126(1):1-14. doi:10.1007/s10549-010-0867-2
28. Nalbant D, Youn H, Nalbant SI, Sharma S, Cobos E, Beale EG, Du Y, Williams SC (2005) FAM20: an evolutionarily conserved family of secreted proteins expressed in hematopoietic cells. BMC Genomics 6:11. doi:10.1186/1471-2164-6-11
29. Oehler MK, Norbury C, Hague S, Rees MCP, Bicknell R (2001) Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth. Oncogene 20(23):2937-2945. doi: 10.1038/sj.onc.1204422
30. Rodriguez-Jimenez FJ, Caldes T, Iniesta P, Vidart JA, Garcia-Asenjo JL, Benito M (2007) Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma. Oncol Rep 17(6):1301-1307
31. Sanz C, Calasanz MJ, Andreu E, Richard C, Prosper F, Fernandez-Luna JL (2004) NALP1 is a transcriptional target for cAMP-response-element-binding protein (CREB) in myeloid leukaemia cells. Biochem J 384(Pt 2):281-286. doi:10.1042/bj20040867
32. Svensson M, Sabharwal H, Hakansson A, Mossberg AK, Lipniunas P, Leffler H, Svanborg C, Linse S (1999) Molecular characterization of alpha-lactalbumin folding variants that induce apoptosis in tumor cells. J Biol Chem 274(10):6388-6396
33. Tai IT, Tang MJ (2008) SPARC in cancer biology: its role in cancer progression and potential for therapy. Drug Resist Update 11(6):231-246. doi:10.1016/j.drup.2008.08.005
34. Ulrix W, Swinnen JV, Heyns W, Verhoeven G (1999) The differentiation- related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells. FEBS Lett 455(1-2):23-26. doi:10.1016/s0014-5793(99)00845- 5
35. Wang V, Davis DA, Veeranna RP, Haque M, Yarchoan R (2010) Characterization of the activation of protein tyrosine phospha-tase, receptor-type, Z polypeptide 1 (PTPRZ1) by hypoxia inducible factor-2 alpha. PLoS ONE 5(3):e9641. doi:10.1371/journal.pone.0009641
36. Yan X, Chua MS, Sun H, So S (2008) N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells. Cancer Lett 262(1):133-142. doi:10.1016/j.canlet.2007.12.010
37. Zhao G, Chen J, Deng Y, Gao F, Zhu J, Feng Z, Lv X, Zhao Z (2011) Identification of NDRG1-regulated genes associated with invasive potential in cervical and ovarian cancer cells. Biochem Biophys Res Commun 408(1):154-159. doi:10.1016/j.bbrc. 2011.03.140
38. Zou H, Wang DF, Can XL, Jiang L, Chen C, Hu LN, Zhang Y (2011) Low TWEAK expression is correlated to the progression of squamous cervical carcinoma. Gynecol Oncol 123(1):123-128. doi:10.1016/j.ygyno.2011.07.003